GSK sees dip in second-quarter sales
Sales decline in the second quarter reflects expected disruption from COVID-19
Read More
Tag: second quarter
GSK ups guidance and unveils major restructure
GlaxoSmithKline has upped its expectations for the year after a strong performance by its vaccines division in the second quarter and the delay of a potential generic version of Advair in the US.
Read More
